|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7580 EUR | -0.52% |
|
-0.26% | -28.36% |
| 07-01 | Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France | CI |
| 06-30 | Amoéba gains from marketing authorization in France |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.52% | -0.26% | -0.13% | -14.16% | -28.36% | -21.69% | +11.96% | -44.10% | -96.93% | 59.7M | |
| +0.12% | -4.13% | -11.24% | -37.91% | -28.42% | -16.97% | -27.93% | -42.85% | +128.01% | 2.94B | |
| -6.18% | -5.34% | -12.33% | +4.66% | +9.76% | +44.05% | +10.93% | -9.00% | +125.68% | 2.51B | |
| -0.35% | -2.04% | -4.63% | -9.28% | +5.29% | -23.17% | -32.04% | -40.64% | - | 1.91B | |
| -2.40% | -2.33% | +1.97% | -10.41% | +2.91% | +17.09% | -3.87% | -24.22% | +94.44% | 1.59B | |
| -1.90% | +1.71% | +3.79% | -13.57% | -17.67% | -26.40% | - | - | - | 1.54B | |
| +2.22% | -1.72% | -12.07% | -34.75% | -15.59% | -11.51% | -50.56% | -35.55% | -4.90% | 1.3B | |
| -5.67% | -0.11% | -7.93% | -14.95% | -16.71% | -16.00% | +20.82% | +67.68% | -15.92% | 1.29B | |
| +1.20% | -5.95% | -20.05% | -40.44% | -26.82% | -5.95% | -27.59% | -18.88% | +85.51% | 1.18B | |
| -1.07% | -8.10% | +2.96% | -10.78% | -1.82% | -25.55% | +64.05% | +33.99% | +6.29% | 1.09B | |
| +0.55% | 0.00% | -2.50% | +19.74% | +16.17% | +12.35% | -48.68% | -39.06% | -64.77% | 727M | |
| +2.75% | -2.39% | -7.23% | -28.73% | -33.28% | -37.29% | -49.04% | -17.31% | -47.34% | 638M | |
| +3.67% | +7.29% | +42.64% | +41.06% | +42.86% | -8.82% | +165.02% | +188.09% | +942.89% | 576M | |
| +0.14% | +0.28% | -2.95% | -8.12% | +2.84% | -10.51% | -30.78% | -17.73% | +13.30% | 539M | |
| +0.99% | -3.22% | -6.23% | -25.16% | -19.45% | -28.46% | -43.76% | -43.51% | - | 528M | |
| +0.64% | -1.37% | -0.38% | -6.71% | -9.49% | -4.58% | +11.55% | +72.17% | +172.16% | 519M | |
| -0.39% | -2.51% | -1.17% | -0.49% | -0.30% | +19.79% | +45.05% | +95.55% | +101.39% | 492M | |
| +0.94% | -4.12% | -3.23% | +2.15% | -11.27% | -35.46% | +34.69% | +4.53% | +58.87% | 490M | |
| +0.39% | -3.42% | -6.78% | -18.30% | -14.17% | -14.02% | -27.80% | -26.12% | -47.99% | 469M | |
| +2.52% | +0.41% | +0.13% | -11.28% | -18.19% | -33.32% | +12.01% | -27.98% | +9.37% | 467M | |
| Average | -0.12% | -2.15% | -2.37% | -10.87% | -8.08% | -11.32% | +1.79% | +3.95% | +85.89% | 1.04B | |
| Weighted average by Cap. | -0.96% | -3.34% | -4.91% | -14.11% | -8.06% | -6.80% | -5.01% | -5.90% | +91.27% |
- Stock Market
- Stocks
- ALMIB Stock
- Sector Amoéba
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
